RE: RNS29 Sep 2023 09:14
A few points from what I can see:
1. Now we understand why there's been limited news, there's been nothing to report
2. Environmental mitigations aside, the financial performance makes for uninspiring reading on our core operational business and everything remaining equal - we are seemingly dependent on seeing some progress at Togo to be able to meet our financial obligation to Shawn Helda next year. Togo appears to be a typical slow start. Hopefully things will not remain equal, otherwise I see a desperate cash call in our future (hopefully director loans, not dilution).
3. The 'jam tomorrow' may prove a saving grace, but without an indication as to the volumes that the liquid blenders wish to acquire, it's hard to assess - I reckon we need to be doubling or trebling current sales through these markets. This potential market could be the game changer we're waiting for, or it could be a contiuation of the snail's pace growth - and leave us short of cash. Who knows? We need news and substance.
4. We are very early in our lifecycle and so we have to hope that the lion's share of foundational work (that was always going to be necessary) has now been completed (testing, relationship building etc) and so we can start to exploit sales growth - as if we continue on the current insipid pathway, we're going to be scratching out a 'liiving' as a company, let alone paying dividends to the beleagured share holder base.
I'll be still sitting tight - but I'm not going to lie, I'm bored of the journey.